Cardiovascular health

Determination of the stroke and heart attack risk

Innovative blood test to determine the individual risk of stroke and heart attack

The PLAC® test is an innovative risk marker that measures the enzymatic activity of Lp-PLA2 (lipoprotein-associated phospholipase A2), a specific biomarker for vascular inflammation involved in the formation of unstable plaques that cause majority of cardiovascular events. 

This easy blood test for the detec­tion of Lp-PLA2 offers a more individual risk assess­ment than the usual examinations. Approximately 70% of the heart attacks and most of the strokes are caused by rupture of vascular de­posits, also called atherosclerotic plaques.

Who should be tested and when?

Men ≥ 45; women ≥ 55 with at least 2 of these risk factors:

  • Hypertension
  • History of cardiovascular diseases or diabetes
  • Overweight
  • Increased cholesterol levels
  • Smoking
  • Lack of exercise

Results and Interpretation

The determination of Lp-PLA2 (a vessel-specific inflammation enzyme) shows if plaques are located within the arte­rial vessel wall that tend to rupture. The PLAC®-Test results allow to stratify the individual risk of a patient and ad­just the treatment depending on the results.

Additional information:

The PLAC®-Test is a CE-labelled test.